Clotting problems and resulting complications are common in COVID-19 patients. Researchers have now shown that a member of the anticoagulant group of drugs not only has a beneficial effect on survival of COVID-19 patients, but also influences the duration of active infection with the SARS-CoV-2 coronavirus.
Click here for original story, Anticoagulant has beneficial side-effects for COVID-19 patients, study finds
Source: ScienceDaily